Brawn Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	1.89	1.99	3.97	4.39	2.25	3.96
Cash & Short-Term Investments	1.89	1.99	3.97	4.39	2.25	3.96
Cash Growth	-21.41%	-49.80%	-9.46%	95.36%	-43.31%	-0.90%
Accounts Receivable	69.34	34.13	38.83	53.15	28.1	92.78
Other Receivables	-	0.14	0.92	0.9	9.27	10.81
Receivables	69.43	34.47	39.96	54.21	37.49	103.74
Inventory	106.23	104.67	60.17	47.91	47.24	2.57
Prepaid Expenses	-	1.84	2.25	2.57	3.25	0.01
Other Current Assets	34.64	32.03	25.05	24.92	31.64	16.97
Total Current Assets	212.19	175	131.4	133.99	121.87	127.25
Property, Plant & Equipment	4.23	4.6	3.33	3.72	3.86	1.42
Long-Term Accounts Receivable	-	20.14	6.59	5.99	5.88	8.55
Long-Term Deferred Tax Assets	5.15	5.15	4.57	1.59	6.24	1.51
Other Long-Term Assets	-	-	0	-	-	-0
Total Assets	221.57	204.89	145.89	145.3	137.85	138.74
Accounts Payable	180.25	82.38	56.75	64.69	40.52	26.59
Accrued Expenses	0.69	2.8	3.5	4.69	4.93	6.2
Current Income Taxes Payable	-	0.26	0.25	1.51	7.22	7.06
Other Current Liabilities	3.57	7.83	4.58	9.58	10.55	9.18
Total Current Liabilities	184.52	93.27	65.08	80.47	63.21	49.03
Pension & Post-Retirement Benefits	-	0.8	1.03	0.83	0.64	1.18
Other Long-Term Liabilities	-	77.2	29.13	0.91	1.79	0.58
Total Liabilities	184.52	171.27	95.24	82.21	65.64	50.79
Common Stock	30	30	30	30	30	30
Additional Paid-In Capital	-	15.2	15.2	15.2	15.2	15.2
Retained Earnings	-	-11.73	5.3	17.74	26.85	42.6
Comprehensive Income & Other	7.05	0.15	0.15	0.15	0.15	0.15
Shareholders' Equity	37.05	33.62	50.65	63.09	72.2	87.95
Total Liabilities & Equity	221.57	204.89	145.89	145.3	137.85	138.74
Net Cash (Debt)	1.89	1.99	3.97	4.39	2.25	3.96
Net Cash Growth	-21.41%	-49.80%	-9.46%	95.36%	-43.31%	-0.90%
Net Cash Per Share	0.68	0.66	1.32	1.46	0.75	1.32
Filing Date Shares Outstanding	2.86	3	3	3	3	3
Total Common Shares Outstanding	2.86	3	3	3	3	3
Working Capital	27.67	81.74	66.32	53.53	58.66	78.23
Book Value Per Share	12.97	11.21	16.88	21.03	24.07	29.31
Tangible Book Value	37.05	33.62	50.65	63.09	72.2	87.95
Tangible Book Value Per Share	12.97	11.21	16.88	21.03	24.07	29.31
Machinery	-	10.24	7.83	7.71	6.75	3.78

Source: S&P Global Market Intelligence. Standard template. Financial Sources.